126 related articles for article (PubMed ID: 11068860)
21. Unusual pattern of phototoxic burning following trimethylpsoralen (TMP) bath photochemotherapy (PUVA).
George SA; Ferguson J
Br J Dermatol; 1992 Oct; 127(4):444-5. PubMed ID: 1419768
[No Abstract] [Full Text] [Related]
22. Treatment of chronic palmoplantar eczema with local bath-PUVA therapy.
Schempp CM; Müller H; Czech W; Schöpf E; Simon JC
J Am Acad Dermatol; 1997 May; 36(5 Pt 1):733-7. PubMed ID: 9146535
[TBL] [Abstract][Full Text] [Related]
23. Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy.
Shephard SE; Panizzon RG
Dermatology; 1999; 199(2):106-12. PubMed ID: 10559574
[TBL] [Abstract][Full Text] [Related]
24. An intraindividual study of the characteristics of erythema induced by bath and oral methoxsalen photochemotherapy and narrowband ultraviolet B.
Man I; Dawe RS; Ferguson J; Ibbotson SH
Photochem Photobiol; 2003 Jul; 78(1):55-60. PubMed ID: 12929749
[TBL] [Abstract][Full Text] [Related]
25. Time course of PUVA erythema.
Man I; Ibbotson SH
J Dermatolog Treat; 2002 Dec; 13(4):179-83. PubMed ID: 19753738
[TBL] [Abstract][Full Text] [Related]
26. Cancer incidence among Finnish patients with psoriasis treated with trioxsalen bath PUVA.
Hannuksela A; Pukkala E; Hannuksela M; Karvonen J
J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):685-9. PubMed ID: 8912561
[TBL] [Abstract][Full Text] [Related]
27. Comparison of minimal phototoxic dose and skin type for determining initial UVA dose in oral liquid methoxsalen photochemotherapy for the treatment of psoriasis.
Rafal ES; Hamilton TA; Gonzalez E
J Invest Dermatol; 1991 Dec; 97(6):1048-52. PubMed ID: 1748814
[TBL] [Abstract][Full Text] [Related]
28. Phototesting in bath-PUVA: marked reduction of 8-methoxypsoralen (8-MOP) activity within one hour after an 8-MOP bath.
Schempp CM; Schöpf E; Simon JC
Photodermatol Photoimmunol Photomed; 1996 Jun; 12(3):100-2. PubMed ID: 8956358
[TBL] [Abstract][Full Text] [Related]
29. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients.
Berne B; Fischer T; Michaëlsson G; Norén P
Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278
[TBL] [Abstract][Full Text] [Related]
30. Trimethylpsoralen bath PUVA is a remittive treatment for psoriasis vulgaris. Evidence that epidermal immunocytes are direct therapeutic targets.
Coven TR; Murphy FP; Gilleaudeau P; Cardinale I; Krueger JG
Arch Dermatol; 1998 Oct; 134(10):1263-8. PubMed ID: 9801682
[TBL] [Abstract][Full Text] [Related]
31. The optimal time to determine the minimal phototoxic dose in skin photosensitized by topical 8 methoxypsoralen.
Man I; Dawe RS; Ferguson J; Ibbotson SH
Br J Dermatol; 2004 Jul; 151(1):179-82. PubMed ID: 15270888
[TBL] [Abstract][Full Text] [Related]
32. Improved prediction of the minimal phototoxic dose in PUVA therapy.
Sakuntabhai A; Matthews JN; Farr PM
Br J Dermatol; 1994 May; 130(5):604-9. PubMed ID: 8204468
[TBL] [Abstract][Full Text] [Related]
33. Bath-5-methoxypsoralen-UVA therapy for psoriasis.
Calzavara-Pinton PG; Zane C; Carlino A; De Panfilis G
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):945-9. PubMed ID: 9204060
[TBL] [Abstract][Full Text] [Related]
34. Correlation between bathing time and photosensitivity in 8-methoxypsoralen (8-MOP) bath PUVA.
Dolezal E; Seeber A; Hönigsmann H; Tanew A
Photodermatol Photoimmunol Photomed; 2000 Aug; 16(4):183-5. PubMed ID: 11019944
[TBL] [Abstract][Full Text] [Related]
35. Large increments in psoralen-ultraviolet A (PUVA) therapy are unsuitable for fair-skinned individuals with psoriasis.
Kirby B; Buckley DA; Rogers S
Br J Dermatol; 1999 Apr; 140(4):661-6. PubMed ID: 10233317
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the minimal phototoxic dose in topical 4,5', 8-trimethylpsoralen PUVA treatment of caucasian skin and of oral mucous membrane.
Kuusilehto A; Lehtinen R; Jansén CT
Acta Derm Venereol; 1990; 70(6):508-9. PubMed ID: 1981425
[TBL] [Abstract][Full Text] [Related]
37. Effects of water temperature on photosensitization in bath-PUVA therapy with 8-methoxypsoralen.
Gruss C; Behrens S; von Kobyletzki G; Reuther T; Husebo L; Altmeyer P; Kerscher M
Photodermatol Photoimmunol Photomed; 1998; 14(5-6):145-7. PubMed ID: 9826883
[TBL] [Abstract][Full Text] [Related]
38. Reduction in 8-methoxypsoralen immersion time alters the erythemal response to bath PUVA.
Azurdia RM; Dean MP; Rhodes LE
Photodermatol Photoimmunol Photomed; 2000 Aug; 16(4):186-8. PubMed ID: 11019945
[TBL] [Abstract][Full Text] [Related]
39. Bath PUVA and psoriasis: is a milder treatment a worse treatment?
Delrosso G; Bornacina C; Farinelli P; Bellinzona F; Leigheb G; Colombo E
Dermatology; 2008; 216(3):191-3. PubMed ID: 18182808
[TBL] [Abstract][Full Text] [Related]
40. The carcinogenic properties of topical PUVA. A lifelong study in mice.
Hannuksela M; Stenbäck F; Lahti A
Arch Dermatol Res; 1986; 278(5):347-51. PubMed ID: 3753032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
